Drug Profile
Thrombin alpha biosimilar - Recpharma
Alternative Names: human recombinant thrombin alpha - RecpharmaLatest Information Update: 28 Jun 2019
Price :
$50
*
At a glance
- Originator Recpharma
- Class Antihaemorrhagics; Blood coagulation factors; Serine endopeptidases
- Mechanism of Action Thrombin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Haemorrhage
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for research development in Haemorrhage in Iran (Topical)
- 20 May 2015 Early research in Haemorrhage in Iran (Topical) before May 2015